COVID-19 Considerations for SEC Reporting Companies

COVID-19 Considerations for SEC Reporting Companies

In 2021, the COVID-19 pandemic continues to raise a number of issues specific to public companies that file reports with the U.S. Securities and Exchange Commission.

During this webinar, our experts addressed the following:

  • SEC COVID-19 guidance
  • SEC disclosure topics
  • Risk factors and forward-looking information disclosures
  • Non-GAAP COVID-19 measures
  • Considerations for correcting or updating disclosures
  • Earnings releases, earnings calls
  • Regulation FD issues
  • Insider trading, share repurchase and enforcement issues
  • Shareholder meeting logistics

Please Note: Recordings of CLE webinars do not qualify for CLE credit.

Latest Articles

Growing U.S.-China Tensions Raise Risks for Companies

To say relations between the United States and China are deteriorating seems like an understatement. Take your pick of reasons why: China’s support ...

At Behest of SEC, Companies Disclose Effects of Russia-Ukraine War on Businesses

When one of the world’s largest countries unilaterally invades a neighboring nation, predicting the impact on global businesses with any degree of c...

Proxy Season Brings Socially Motivated Shareholder Proposals from Both Sides of the Aisle

It’s nothing new to see activists showing up at annual shareholder meetings to protest banks’ social agendas. In fact, they’re typically taking ...